Professional Documents
Culture Documents
CHP 66 Common Problems of Critical Care Patients
CHP 66 Common Problems of Critical Care Patients
Nutrition:
o The primary goal of nutritional support is to prevent or correct nutritional
deficiencies. This is usually accomplished by the early provision of enteral
nutrition (i.e., delivery of calories via the gastrointestinal [GI] tract) or parenteral
nutrition (i.e., delivery of calories intravenously).
o Parenteral nutrition should be considered only when the enteral route is
unsuccessful in providing adequate nutrition or contraindicated (e.g., paralytic
ileus, diffuse peritonitis, intestinal obstruction, pancreatitis, GI ischemia,
intractable vomiting, and severe diarrhea).
Anxiety:
o The primary sources of anxiety for patients include the perceived or anticipated
threat to physical health, actual loss of control or body functions, and an
environment that is foreign.
o Assessing patients for anxiety is very important and clinical indicators can include
agitation, increased blood pressure, increased heart rate, patient verbalization of
anxiety, and restlessness.
o To help reduce anxiety, the nurse should encourage patients and families to
express concerns, ask questions, and state their needs; and include the patient and
family in all conversations and explain the purpose of equipment and procedures.
o Antianxiety drugs and complementary therapies may reduce the stress response
and should be considered.
Pain:
o The control of pain in the ICU patient is paramount as inadequate pain control is
often linked with agitation and anxiety and can contribute to the stress response.
o ICU patients at high risk for pain include patients (1) who have medical
conditions that include ischemic, infectious, or inflammatory processes; (2) who
are immobilized; (3) who have invasive monitoring devices, including
endotracheal tubes; (4) and who are scheduled for any invasive or noninvasive
procedures.
o Continuous intravenous sedation and an analgesic agent are a practical and
effective strategy for sedation and pain control.
Impaired communication:
o Inability to communicate can be distressing for the patient who may be unable to
speak because of sedative and paralyzing drugs or an endotracheal tube.
o The nurse should explore alternative methods of communication, including the
use of devices such as picture boards, notepads, magic slates, or computer
keyboards. For patients who do not speak English, the use of an interpreter is
recommended.
o Nonverbal communication is important. Comforting touch with ongoing
evaluation of the patient’s response should be provided. Families should be
encouraged to touch and talk with the patient even if the patient is unresponsive or
comatose.
Sensory-perceptual problems:
o Delirium in ICU patients ranges from 15% to 40%.
Demographic factors predisposing the patient to delirium include
advanced age, preexisting cerebral illnesses, use of medications that block
rapid eye movement sleep, and a history of drug or alcohol abuse.
Environmental factors that can contribute to delirium include sleep
deprivation, anxiety, sensory overload, and immobilization.
Physical conditions such as hemodynamic instability, hypoxemia,
hypercarbia, electrolyte disturbances, and severe infections can precipitate
delirium.
Certain drugs (e.g., sedatives, furosemide, antimicrobials) have been
associated with the development of delirium.
The ICU nurse must identify predisposing factors that may precipitate
delirium and improve the patient’s mental clarity and cooperation with
appropriate therapy (e.g., correction of oxygenation, use of clocks and
calendars).
If the patient demonstrates unsafe behavior, hyperactivity, insomnia, or
delusions, symptoms may be managed with neuroleptic drugs (e.g.,
haloperidol).
The presence of family members may help reorient the patient and reduce
agitation.
o Sensory overload can also result in patient distress and anxiety.
Environmental noise levels are particularly high in the ICU and the nurse
should limit noise and assist the patient in understanding noises that
cannot be prevented.
Sleep problems:
o Patients may have difficulty falling asleep or have disrupted sleep because of
noise, anxiety, pain, frequent monitoring, or treatment procedures.
o Sleep disturbance is a significant stressor in the ICU, contributing to delirium and
possibly affecting recovery.
o The environment should be structured to promote the patient’s sleep-wake cycle
by clustering activities, scheduling rest periods, dimming lights at nighttime,
opening curtains during the daytime, obtaining physiologic measurements without
disrupting the patient, limiting noise, and providing comfort measures.
o Benzodiazepines and benzodiazepine-like drugs can be used to induce and
maintain sleep.
HEMODYNAMIC MONITORING
Hemodynamic monitoring refers to the measurement of pressure, flow, and oxygenation
within the cardiovascular system. Both invasive and noninvasive hemodynamic
measurements are made in the ICU.
Values commonly measured include systemic and pulmonary arterial pressures, central
venous pressure (CVP), pulmonary artery wedge pressure (PAWP), cardiac output/index,
stroke volume/index, and oxygen saturation of the hemoglobin of arterial blood (SaO2)
and mixed venous blood (SvO2).
Cardiac output (CO) is the volume of blood pumped by the heart in 1 minute. Cardiac
index (CI) is the measurement of the CO adjusted for body size.
The volume ejected with each heartbeat is the stroke volume (SV). Stroke volume index
(SVI) is the measurement of SV adjusted for body size.
The opposition to blood flow offered by the vessels is called systemic vascular resistance
(SVR) or pulmonary vascular resistance (PVR).
Preload, afterload, and contractility determine SV (and thus CO and blood pressure).
CVP, measured in the right atrium or in the vena cava close to the heart, is the right
ventricular preload or right ventricular end-diastolic pressure under normal conditions.
Afterload refers to the forces opposing ventricular ejection and includes systemic arterial
pressure, the resistance offered by the aortic valve, and the mass and density of the blood
to be moved.
Systemic vascular resistance (SVR) is the resistance of the systemic vascular bed.
Pulmonary vascular resistance (PVR) is the resistance of the pulmonary vascular bed.
Both of these measures can be adjusted for body size.
SVR, SVR index, SV, and SV index can be calculated each time that CO is measured.
o Increased SVR indicates vasoconstriction from shock, hypertension, increased
release or administration of epinephrine and other vasoactive inotropes, or left
ventricular failure.
o Decreased SVR indicates vasodilation, which may occur during shock states (e.g.,
septic, neurogenic) or with drugs that reduce afterload.
o Changes in SV are becoming more important indicators of the pumping status of
the heart than other parameters.
Complications with PA Catheters
Infection and sepsis are serious problems associated with PA catheters.
o Careful surgical asepsis for insertion and maintenance of the catheter and attached
tubing is mandatory.
o Flush bag, pressure tubing, transducer, and stopcock should be changed every 96
hours.
Pulmonary infarction or PA rupture from: (1) balloon rupture, releasing air and fragments
that could embolize; (2) prolonged balloon inflation obstructing blood flow; (3) catheter
advancing into a wedge position, obstructing blood flow; and (4) thrombus formation and
embolization.
o Balloon must never be inflated beyond the balloon’s capacity (usually 1 to 1.5 ml
of air). And must not be left inflated for more than four breaths (except during
insertion) or 8 to 15 seconds.
o PA pressure waveforms are monitored continuously for evidence of catheter
occlusion, dislocation, or spontaneous wedging.
o PA catheter is continuously flushed with a slow infusion of heparinized (unless
contraindicated) saline solution.
Ventricular dysrhythmias can occur during PA catheter insertion or removal or if the tip
migrates back from the PA to the right ventricle and irritates the ventricular wall.
The nurse may observe that the PA catheter cannot be wedged and may need to be
repositioned by the physician or a qualified nurse.
ARTIFICIAL AIRWAYS
Endotracheal intubation (ET intubation) involves the placement of a tube into the
trachea via the mouth or nose past the larynx.
Indications for ET intubation include (1) upper airway obstruction (e.g., secondary to
burns, tumor, bleeding), (2) apnea, (3) high risk of aspiration, (4) ineffective clearance of
secretions, and (5) respiratory distress.
A tracheotomy is a surgical procedure that is performed when the need for an artificial
airway is expected to be long term.
Oral ET intubation is the procedure of choice for most emergencies because the airway
can be secured rapidly, a larger diameter tube can be used thus reducing the work of
breathing (WOB) and making it easier to remove secretions and perform fiberoptic
bronchoscopy.
Following intubation, the cuff is inflated, and the placement of the ET tube is confirmed
while manually ventilating the patient with 100% O2.
o An end-tidal CO2 detector is to confirm proper placement by measuring the
amount of exhaled CO2 from the lungs.
The detector is placed between the BVM and the ET tube and either
observed for a color change (indicating the presence of CO2) or a number.
If no CO2 is detected, than the tube is in the esophagus.
o The lung bases and apices are auscultated for bilateral breath sounds, and the
chest is observed for symmetric chest wall movement.
o A portable chest x-ray is immediately obtained to confirm tube location (3 to 5 cm
above the carina in the adult).
Positive pressure ventilation (PPV), used primarily with acutely ill patients, pushes air
into the lungs under positive pressure during inspiration. Expiration occurs passively as
in normal expiration. Modes of PPV are categorized into two groups:
o Volume ventilation involves a predetermined tidal volume (VT) that is delivered
with each inspiration, while the amount of pressure needed to deliver the breath
varies based on the compliance and resistance factors of the patient-ventilator
system.
o Pressure ventilation involves a predetermined peak inspiratory pressure while
the VT delivered to the patient varies based on the selected pressure and the
compliance and resistance factors of the patient-ventilator system.
Careful attention must be given to the VT to prevent unplanned
hyperventilation or hypoventilation.
Pulmonary System
As lung inflation pressures increase, risk of barotrauma increases.
o Patients with compliant lungs (e.g., COPD) are at greater risk for barotraumas.
o Air can escape into the pleural space from alveoli or interstitium, accumulate, and
become trapped causing a pneumothorax.
o For some patients, chest tubes may be placed prophylactically.
Pneumomediastinum usually begins with rupture of alveoli into the lung interstitium;
progressive air movement then occurs into the mediastinum and subcutaneous neck
tissue. This is commonly followed by pneumothorax.
Volutrauma in PPV relates to the lung injury that occurs when large tidal volumes are
used to ventilate noncompliant lungs (e.g., ARDS).
o Volutrauma results in alveolar fractures and movement of fluids and proteins into
the alveolar spaces.
Respiratory alkalosis can occur if the respiratory rate or VT is set too high (mechanical
overventilation) or if the patient receiving assisted ventilation is hyperventilating.
o If hyperventilation is spontaneous, it is important to determine the cause (e.g.,
hypoxemia, pain, fear, anxiety, or compensation for metabolic acidosis) and treat
it.
Progressive fluid retention often occurs after 48 to 72 hours of PPV especially PPV with
PEEP. It is associated with decreased urinary output and increased sodium retention.
o Fluid balance changes may be due to decreased CO.
o Results include diminished renal perfusion, the release of renin with subsequent
production of angiotensin and aldosterone resulting in sodium and water
retention.
o Pressure changes within the thorax are associated with decreased release of atrial
natriuretic peptide, also causing sodium retention.
o As a part of the stress response, release of antidiuretic hormone (ADH) and
cortisol may be increased, contributing to sodium and water retention.
Neurologic System
In patients with head injury, PPV, especially with PEEP, can impair cerebral blood flow.
Elevating the head of the bed and keeping the patient’s head in alignment may decrease
the deleterious effects of PPV on intracranial pressure.
Gastrointestinal System
Ventilated patients are at risk for developing stress ulcers and GI bleeding.
Reduction of CO caused by PPV may contribute to ischemia of the gastric and intestinal
mucosa and possibly increase the risk of translocation of GI bacteria.
Gastric and bowel dilation may occur as a result of gas accumulation in the GI tract from
swallowed air. Decompression of the stomach can be accomplished by the insertion of an
NG/OG tube.
Immobility, sedation, circulatory impairment, decreased oral intake, use of opioid pain
medications, and stress contribute to decreased peristalsis. The patient’s inability to
exhale against a closed glottis may make defecation difficult predisposing the patient to
constipation.
Musculoskeletal System
Maintenance of muscle strength and prevention of the problems associated with
immobility are important.
Passive and active exercises, consisting of movements to maintain muscle tone in the
upper and lower extremities, should be done in bed.
Prevention of contractures, pressure ulcers, foot drop, and external rotation of the hip and
legs by proper positioning is important.
Psychosocial Needs
Patients may experience physical and emotional stress due to the inability to speak, eat,
move, or breathe normally.
Tubes and machines may cause pain, fear, and anxiety.
Ordinary activities of daily living such as eating, elimination, and coughing are extremely
complicated.
Patients have identified four needs: need to know (information), need to regain control,
need to hope, and need to trust. When these needs were met, they felt safe.
The nurse should encourage hope and build trusting relationships with the patient and
family.
Patients receiving PPV usually require some type of sedation and/or analgesia to facilitate
optimal ventilation.
At times the decision is made to paralyze the patient with a neuromuscular blocking agent
to provide more effective synchrony with the ventilator and increased oxygenation.
o If the patient is paralyzed, the nurse should remember that the patient can hear,
see, think, and feel.
o Intravenous sedation and analgesia must always be administered concurrently
when the patient is paralyzed.
o Assessment of the patient should include train-of-four (TOF) peripheral nerve
stimulation, physiologic signs of pain or anxiety (changes in heart rate and blood
pressure), and ventilator synchrony.
Many patients have few memories of their time in the ICU, whereas others remember
vivid details.
The most frequent site for disconnection is between the tracheal tube and the adapter.
Alarms can be paused (not inactivated) during suctioning or removal from the ventilator
and should always be reactivated before leaving the patient’s bedside.
Ventilator malfunction may also occur and may be related to several factors (e.g., power
failure, failure of oxygen supply).
Patients should be disconnected from the machine and manually ventilated with 100%
oxygen if machine failure/malfunction is determined.
Patients likely to be without food for 3 to 5 days should have a nutritional program
initiated.
Poor nutrition and the disuse of respiratory muscles contribute to decreased respiratory
muscle strength.
Inadequate nutrition can delay weaning, decrease resistance to infection, and decrease the
speed of recovery.
Enteral feeding via a small-bore feeding tube is the preferred method to meet caloric
needs of ventilated patients.
A concern regarding the nutritional support of patients receiving PPV is the carbohydrate
content of the diet.
o Metabolism of carbohydrates may contribute to an increase in serum CO2 levels
resulting in a higher required minute ventilation and an increase in WOB.
o Limiting carbohydrate content in the diet may lower CO2 production.
o The dietitian should be consulted to determine the caloric and nutrient needs of these
patients.
The weaning process differs for patients requiring short-term ventilation (up to 3 days)
versus long-term ventilation (more than 3 days).
o Patients requiring short-term ventilation (e.g., after cardiac surgery) will
experience a linear weaning process.
o Patients requiring prolonged PPV will experience a weaning process that consists
of peaks and valleys.
Weaning can be viewed as consisting of three phases. The preweaning, or assessment,
phase determines the patient’s ability to breathe spontaneously.
Weaning assessment parameters include criteria to assess muscle strength
and endurance, and minute ventilation and rapid shallow breathing index.
Lungs should be reasonably clear on auscultation and chest x-ray.
Nonrespiratory factors include the assessment of the patient’s neurologic
status, hemodynamics, fluid and electrolytes/acid-base balance, nutrition,
and hemoglobin.
Drugs should be titrated to achieve comfort without causing excessive
drowsiness.
o Evidenced-based clinical guidelines recommend a spontaneous breathing trial
(SBT) in patients who demonstrate weaning readiness, the second phase.
An SBT should be at least 30 minutes but no longer than 120 minutes and
may be done with low levels of CPAP, low levels of PS or a “T” piece.
Tolerance of the trial may lead to extubation but failure to tolerate a SBT
should prompt a search for reversible factors and a return to a nonfatiguing
ventilator modality.
The use of a standard approach for weaning or weaning protocols have shown to decrease
ventilator days.
Weaning is usually carried out during the day, with the patient ventilated at night in a rest
mode.
The patient being weaned and the family should be provided with explanations regarding
weaning and ongoing psychologic support.
The patient should be placed in a sitting or semirecumbent position and baseline vital
signs and respiratory parameters measured.
During the weaning trial, the patient must be monitored closely for noninvasive criteria
that may signal intolerance and result in cessation of the trial (e.g., tachypnea,
tachycardia, dysrhythmias, sustained desaturation [SpO2 <91%], hypertension, agitation,
anxiety, sustained VT <5 ml/kg, changes in level of consciousness).
The weaning outcome phase refers to the period when weaning stops and the patient is
extubated or weaning is stopped because no further progress is being made.
After extubation, the patient should be encouraged to deep breathe and cough, and the
pharynx should be suctioned as needed.
Vital signs, respiratory status, and oxygenation are monitored immediately following
extubation, within 1 hour, and per institutional policy.